In an article in the New York Times, reporter Pam Belluck explores all of the male-based methods of contraception currently in development that promise to be more long-term than a condom and require less commitment than a vasectomy. What's remarkable about that story is how similarly it reads to the development of female contraceptives.
And it turns out that when it comes to grappling with hormonally-based contraceptive medication, female hormones may be critical in interfering with sperm's ability to start a pregnancy. Belluck reports that a cocktail of the female hormone progestin and the male hormone testosterone may be among the first methods approved. The progestin tricks the brain into signaling the testes to stop producing testosterone, which in turn stops the production of sperm. Testosterone is added in the pill to avoid diminished libido and muscle loss, which can result when the hormone's levels drop too low. So far, in early tests, the agent worked on 95% of the men who tried it, but there are lingering questions about the long-term effects of suppressing testosterone in men.
Such combinations of hormones are already widely used in several female contraceptives, however, such as patches and rings, which package progestin with another female hormone, estrogen. While the two methods work in different ways to inhibit fertilization, their side effects are surprisingly similar.
No comments:
Post a Comment